ReviewClinical therapeutics2015

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.

Kathleen M Mahoney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.